Daiwa Securities Group’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-149
Closed -$1K 1374
2025
Q2
$1K Hold
149
﹤0.01% 1285
2025
Q1
$1K Hold
149
﹤0.01% 1255
2024
Q4
$2K Hold
149
﹤0.01% 1234
2024
Q3
$2K Hold
149
﹤0.01% 1235
2024
Q2
$2K Hold
149
﹤0.01% 1267
2024
Q1
$1K Buy
+149
New +$1.45K ﹤0.01% 1306

Other funds holding THRD

Daiwa Securities Group's THRD Position: Q3 2025 in Review

Daiwa Securities Group sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 149 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in THRD in Q1 2024 and held it in 6 quarters. The position peaked at $2K in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Daiwa Securities Group reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 149 Third Harmonic Bio shares in Q3 2025, an estimated $1K.
  • Daiwa Securities Group first reported a position in Third Harmonic Bio in Q1 2024 and held it in 6 quarters.
  • Daiwa Securities Group's Third Harmonic Bio position peaked at $2K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.